Autoimmune Diseases  >>  Simulect (basiliximab)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Simulect (basiliximab) / Novartis
NCT00468117: Efficacy of Islet After Kidney Transplantation

Completed
3
24
US, Canada
Islet transplantation, Antithymocyte Globulin, ATG, Daclizumab or Basiliximab, Etanercept, Allogenic human purified pancreatic islets
National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes Mellitus
07/15
07/17

Download Options